Matches in Wikidata for { <http://www.wikidata.org/entity/Q37033058> ?p ?o ?g. }
- Q37033058 description "article científic" @default.
- Q37033058 description "article scientifique" @default.
- Q37033058 description "articolo scientifico" @default.
- Q37033058 description "artigo científico" @default.
- Q37033058 description "artículu científicu espublizáu en 2016" @default.
- Q37033058 description "bilimsel makale" @default.
- Q37033058 description "scientific article published on 07 April 2016" @default.
- Q37033058 description "vedecký článok" @default.
- Q37033058 description "vetenskaplig artikel" @default.
- Q37033058 description "videnskabelig artikel" @default.
- Q37033058 description "vědecký článek" @default.
- Q37033058 description "wetenschappelijk artikel" @default.
- Q37033058 description "wissenschaftlicher Artikel" @default.
- Q37033058 description "наукова стаття, опублікована у квітні 2016" @default.
- Q37033058 description "научни чланак" @default.
- Q37033058 description "مقالة علمية نشرت في 07 أبريل 2016" @default.
- Q37033058 name "No Evidence of Pritelivir Resistance Among Herpes Simplex Virus Type 2 Isolates After 4 Weeks of Daily Therapy" @default.
- Q37033058 name "No Evidence of Pritelivir Resistance Among Herpes Simplex Virus Type 2 Isolates After 4 Weeks of Daily Therapy" @default.
- Q37033058 name "No Evidence of Pritelivir Resistance Among Herpes Simplex Virus Type 2 Isolates After 4 Weeks of Daily Therapy." @default.
- Q37033058 type Item @default.
- Q37033058 label "No Evidence of Pritelivir Resistance Among Herpes Simplex Virus Type 2 Isolates After 4 Weeks of Daily Therapy" @default.
- Q37033058 label "No Evidence of Pritelivir Resistance Among Herpes Simplex Virus Type 2 Isolates After 4 Weeks of Daily Therapy" @default.
- Q37033058 label "No Evidence of Pritelivir Resistance Among Herpes Simplex Virus Type 2 Isolates After 4 Weeks of Daily Therapy." @default.
- Q37033058 prefLabel "No Evidence of Pritelivir Resistance Among Herpes Simplex Virus Type 2 Isolates After 4 Weeks of Daily Therapy" @default.
- Q37033058 prefLabel "No Evidence of Pritelivir Resistance Among Herpes Simplex Virus Type 2 Isolates After 4 Weeks of Daily Therapy" @default.
- Q37033058 prefLabel "No Evidence of Pritelivir Resistance Among Herpes Simplex Virus Type 2 Isolates After 4 Weeks of Daily Therapy." @default.
- Q37033058 P1433 Q37033058-D38C7BAD-F1B4-4752-9658-4B596439B4D4 @default.
- Q37033058 P1476 Q37033058-54AC4AA2-003C-4C97-9903-E9CDE508D10C @default.
- Q37033058 P2093 Q37033058-0E17F5A3-9D7A-4070-A710-AA06484DB758 @default.
- Q37033058 P2093 Q37033058-3638A362-B5CC-4EF8-9668-90BB56E801E9 @default.
- Q37033058 P2093 Q37033058-9766BD34-952C-4B5F-ACC0-7B2491C227C8 @default.
- Q37033058 P2093 Q37033058-E9936A2F-E8A7-472F-8316-0672E69C5237 @default.
- Q37033058 P2093 Q37033058-ED8AC640-6263-48A9-AD55-B7F60F7143AA @default.
- Q37033058 P2860 Q37033058-187D1258-37AB-4AB0-B218-A9A18EA3B147 @default.
- Q37033058 P2860 Q37033058-1CCA6F7C-37FE-4DAA-9B83-4616C935031A @default.
- Q37033058 P2860 Q37033058-35DBBE86-C54F-4D0C-907E-653C0779124A @default.
- Q37033058 P2860 Q37033058-41EC07D9-CE0D-4A2B-B243-64CA82569C61 @default.
- Q37033058 P2860 Q37033058-44B6E684-DF2D-42A4-B0CA-9BFC42058195 @default.
- Q37033058 P2860 Q37033058-4DBA6CF8-61EB-4E11-9A55-4DF5EE405B18 @default.
- Q37033058 P2860 Q37033058-5D0A61EB-D12D-4CE7-838F-3450E1BB95A1 @default.
- Q37033058 P2860 Q37033058-659B622E-CF5A-4DB3-A3A9-3EEED038ED2C @default.
- Q37033058 P2860 Q37033058-66C40CA6-7B55-4A5F-A487-697EC273D42A @default.
- Q37033058 P2860 Q37033058-6C879FE8-6556-4264-8C09-65A0DE072553 @default.
- Q37033058 P2860 Q37033058-88525A6D-8D0C-4665-97BA-981F00A1B8B0 @default.
- Q37033058 P2860 Q37033058-8C767962-CA3A-4168-89EA-414EB208BB42 @default.
- Q37033058 P2860 Q37033058-8F8CC198-ADD3-418F-AE5F-9847C137A327 @default.
- Q37033058 P2860 Q37033058-94B99B80-44F2-49EA-BDEF-91BCEA93C36A @default.
- Q37033058 P2860 Q37033058-9524C52E-023A-46C4-AA01-530D35371DB6 @default.
- Q37033058 P2860 Q37033058-A3CF859A-5197-403B-A75C-5403D31DB2F9 @default.
- Q37033058 P2860 Q37033058-B7509000-675F-4594-B834-92DC823D2AE8 @default.
- Q37033058 P2860 Q37033058-BA3CD613-3620-4852-A247-3FBADA9EF5CF @default.
- Q37033058 P2860 Q37033058-F2BF84A7-FE99-4CD6-9B5B-16DA2E78F6F2 @default.
- Q37033058 P2860 Q37033058-F471C2EE-684F-47F3-AFBD-8D03C63F0866 @default.
- Q37033058 P2860 Q37033058-F5A3C35F-95CB-4281-85D3-B5B61A5995C9 @default.
- Q37033058 P2860 Q37033058-FAFC6310-B5AF-467B-BF0F-2E97D493027F @default.
- Q37033058 P304 Q37033058-CAF73033-B6A7-4139-83F0-41F50B662A4C @default.
- Q37033058 P31 Q37033058-1AEDA461-51EE-4671-A100-FFE755DD868D @default.
- Q37033058 P356 Q37033058-AD98C770-B30A-4BAA-A77A-47E51DB3C0A5 @default.
- Q37033058 P407 Q37033058-572303F9-A979-4BF1-98D9-D70A42A04AE8 @default.
- Q37033058 P433 Q37033058-CDDD2A36-5026-438B-BCCB-409A673618AB @default.
- Q37033058 P478 Q37033058-00CBED76-A41E-4A42-ABC7-453A19A47F60 @default.
- Q37033058 P50 Q37033058-1517B68D-4F9E-40B5-8783-99A8C727B511 @default.
- Q37033058 P50 Q37033058-1B0B743C-8369-48D3-8407-C8EB8303B605 @default.
- Q37033058 P50 Q37033058-1D90C363-9FF1-44ED-89E6-B0337F9BD07D @default.
- Q37033058 P50 Q37033058-384B14FB-B8E5-468F-A16B-47412EBBC6A0 @default.
- Q37033058 P50 Q37033058-547131CA-B17A-47B7-B081-22249BEDC7D3 @default.
- Q37033058 P50 Q37033058-7DEECDC9-5B46-413A-833D-B4B94479F54E @default.
- Q37033058 P50 Q37033058-A0EEF450-5288-4084-8CDD-0CB0DF472948 @default.
- Q37033058 P50 Q37033058-A57E0072-B330-46C7-9ADF-23A803B37991 @default.
- Q37033058 P50 Q37033058-E889AD6B-86AE-4E79-A5DB-E1E1B13E0629 @default.
- Q37033058 P577 Q37033058-36AD9F48-F778-4ADE-A08A-9EE96D6533EF @default.
- Q37033058 P5875 Q37033058-766C21D5-A37C-471E-A2F3-2246C3828F0E @default.
- Q37033058 P698 Q37033058-7D50F4D8-0A2F-446D-9129-BD1C1235F6E9 @default.
- Q37033058 P932 Q37033058-B1FB630C-FCBA-4BCC-82C1-C7C3BE88A30C @default.
- Q37033058 P356 JIW129 @default.
- Q37033058 P698 27056950 @default.
- Q37033058 P1433 Q4051141 @default.
- Q37033058 P1476 "No Evidence of Pritelivir Resistance Among Herpes Simplex Virus Type 2 Isolates After 4 Weeks of Daily Therapy" @default.
- Q37033058 P2093 "Craig A Magaret" @default.
- Q37033058 P2093 "Holger Zimmermann" @default.
- Q37033058 P2093 "Jia Jin Kee" @default.
- Q37033058 P2093 "Paul T Edlefsen" @default.
- Q37033058 P2093 "Thomas Goldner" @default.
- Q37033058 P2860 Q27860491 @default.
- Q37033058 P2860 Q29547584 @default.
- Q37033058 P2860 Q33963010 @default.
- Q37033058 P2860 Q34579981 @default.
- Q37033058 P2860 Q35021627 @default.
- Q37033058 P2860 Q35879617 @default.
- Q37033058 P2860 Q35914336 @default.
- Q37033058 P2860 Q36192926 @default.
- Q37033058 P2860 Q37210250 @default.
- Q37033058 P2860 Q37823763 @default.
- Q37033058 P2860 Q39577774 @default.
- Q37033058 P2860 Q39721721 @default.
- Q37033058 P2860 Q42188483 @default.
- Q37033058 P2860 Q42243140 @default.
- Q37033058 P2860 Q42270920 @default.
- Q37033058 P2860 Q44661886 @default.
- Q37033058 P2860 Q44830414 @default.